Linked e-resources
Details
Table of Contents
Intro
Preface
Acknowledgements
Editor biography
Lead editor Dr Nanasaheb Thorat, MSc, PhD (Gold Medal), MRSC
List of contributors
Outline placeholder
Professor Niroj Sahu
Dr Sandeep B Somvanshi
Chapter 1 Introduction to cancer nanomedicine and nanotheranostics
1.1 Introduction
1.2 Nanotheranostics and nanomedicine
1.3 Nanomedicine as contrast agents for localized imaging
1.4 Nanomedicines for imaging-guided cancer therapy
1.5 Nanotheranostics in cancer treatments
1.5.1 Gold nanoparticles
1.5.2 Magnetic nanoparticles
1.5.3 Mesoporous silica nanoparticles
1.5.4 Dendrimers
1.5.5 Polymeric nanoparticles
1.6 Nanomedicine interaction with tumor environment and its clearance pathways
1.7 Clinical status of nanomedicines
1.8 Conclusion
References
Chapter 2 Introduction to imaging modalities
2.1 Introduction
2.2 Different types of imaging modalities
Computed tomography
Magnetic resonance imaging (MRI)
Ultrasound imaging (US)
X-ray imaging
Positron emission tomography (PET)
Differences between PET, CT and MRI scanning
2.2.1 Basics and fundamentals of imaging techniques
Magnetic resonance imaging (MRI)
Computed tomography (CT)
Optical imaging (OI)
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT)
Photo-acoustic imaging (PAI)
2.3 Imaging modalities for cancer management
2.3.1 Diagnostics
2.3.2 Therapy monitoring
2.4 Conclusion
References
Chapter 3 Nanoplatforms for cancer imagining
3.1 Introduction
3.2 Nanomedicines for cancer imaging
3.2.1 Types of nanoplatforms as imaging agents
3.3 Nanomedicines and radio-imaging techniques
3.4 Nanomedicines and new generation imaging techniques
3.5 Conclusions
Acknowledgments
References.
Chapter 4 Synergy between nanomedicine and tumor imaging
4.1 Introduction
4.2 Multifunctional nanoplatforms for cancer diagnosis
4.3 Nanoplatforms for therapy monitoring using imaging techniques
4.4 Image-guided nanomedicine animal models and clinical implications
4.5 Conclusions
Conflict of interest
Acknowledgments
References.
Preface
Acknowledgements
Editor biography
Lead editor Dr Nanasaheb Thorat, MSc, PhD (Gold Medal), MRSC
List of contributors
Outline placeholder
Professor Niroj Sahu
Dr Sandeep B Somvanshi
Chapter 1 Introduction to cancer nanomedicine and nanotheranostics
1.1 Introduction
1.2 Nanotheranostics and nanomedicine
1.3 Nanomedicine as contrast agents for localized imaging
1.4 Nanomedicines for imaging-guided cancer therapy
1.5 Nanotheranostics in cancer treatments
1.5.1 Gold nanoparticles
1.5.2 Magnetic nanoparticles
1.5.3 Mesoporous silica nanoparticles
1.5.4 Dendrimers
1.5.5 Polymeric nanoparticles
1.6 Nanomedicine interaction with tumor environment and its clearance pathways
1.7 Clinical status of nanomedicines
1.8 Conclusion
References
Chapter 2 Introduction to imaging modalities
2.1 Introduction
2.2 Different types of imaging modalities
Computed tomography
Magnetic resonance imaging (MRI)
Ultrasound imaging (US)
X-ray imaging
Positron emission tomography (PET)
Differences between PET, CT and MRI scanning
2.2.1 Basics and fundamentals of imaging techniques
Magnetic resonance imaging (MRI)
Computed tomography (CT)
Optical imaging (OI)
Positron emission tomography (PET) and single-photon emission computed tomography (SPECT)
Photo-acoustic imaging (PAI)
2.3 Imaging modalities for cancer management
2.3.1 Diagnostics
2.3.2 Therapy monitoring
2.4 Conclusion
References
Chapter 3 Nanoplatforms for cancer imagining
3.1 Introduction
3.2 Nanomedicines for cancer imaging
3.2.1 Types of nanoplatforms as imaging agents
3.3 Nanomedicines and radio-imaging techniques
3.4 Nanomedicines and new generation imaging techniques
3.5 Conclusions
Acknowledgments
References.
Chapter 4 Synergy between nanomedicine and tumor imaging
4.1 Introduction
4.2 Multifunctional nanoplatforms for cancer diagnosis
4.3 Nanoplatforms for therapy monitoring using imaging techniques
4.4 Image-guided nanomedicine animal models and clinical implications
4.5 Conclusions
Conflict of interest
Acknowledgments
References.